HIRSCHMAN ORIN 13D/13G Filings for Immix Biopharma, Inc. (IMMX)

HIRSCHMAN ORIN 13D and 13G filings for Immix Biopharma, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2025-01-29
06:17 am
Sale		 2024-12-31 13G Immix Biopharma, Inc.
IMMX		 HIRSCHMAN ORIN 0
0.000%		 -1,455,000decrease
(Position Closed)		 Filing
2024-02-07
09:18 am
Purchase		 2024-02-06 13G Immix Biopharma, Inc.
IMMX		 HIRSCHMAN ORIN 1,455,000
5.800%		 1,455,000increase
(New Position)		 Filing